内視鏡的逆行性胆管膵管造影の市場規模、シェア、動向分析レポート：製品タイプ別、手技タイプ別、最終用途別、地域別、セグメント別予測、2025年～2030年

市場規模と動向

世界の内視鏡的逆行性胆管膵管造影の市場規模は2024年に21億7,000万米ドルと推定され、2025～2030年にかけてCAGR 8.26％で成長すると予測されています。

この成長は、胆石、膵炎、胆管閉塞などの膵・胆道疾患の罹患率の上昇がERCP手技の需要を煽っていることが主因です。人口の高齢化とライフスタイルの変化に伴い、これらの疾患の有病率は増加し、市場の成長を促進すると予想されます。2024年2月に発表されたClinical Gastroenterology and Hepatologyの調査によると、胆石の有病率は世界全体で推定6%であり、女性と南米でより高い有病率が観察されています。調査によると、胆石の罹患率は予測期間中に急上昇すると予想され、それによって内視鏡的逆行性胆管膵管造影（ERCP）手技の需要を促進します。

さらに、内視鏡技術の進歩により、ERCP手技の安全性と有効性が向上しています。例えば、Advantechは2023年1月、内視鏡技術セグメントにおける画期的なイノベーションとしてMIO-5377Rシングルボードコンピュータを発表しました。このコンパクトで強力なデバイスは、内視鏡が直面する従来の課題に対処するために設計されており、性能、信頼性、機能性を向上させています。さらに、高精細画像、内視鏡の操作性向上、治療用アクセサリーの開発などの技術革新により、ERCPはより精密で効果的な診断・治療ツールとなりました。このような技術的進歩により、医療プロバイダーと患者の両方がERCP手技を選択するようになっています。

低侵襲手術手技の採用が増加したことで、ERCP手技の需要が増加しており、今後数年間で産業の成長を促進すると予想されています。例えば、2024年1月に発表された米国がん協会の年次報告書によると、米国では推定41,630件の肝臓がんの新規症例が診断されると予想されています。さらに、同じ情報源によると、肝臓がんは米国と比較して東南アジア以南やサハラ・アフリカの国々でより一般的です。さらに、肝がんは世界的にがん関連死亡の主要原因となっており、毎年70万人以上の命を奪っています。

胆管がんや肝細胞がんの負担が大きいことから、こうした悪性腫瘍の早期発見のための内視鏡的逆行性胆管膵管造影の需要が高まると予想されます。

さらに、膵臓・胆道疾患の早期診断・治療の利点に対する意識の高まりが、ERCPのような低侵襲手技に対する需要の高まりにつながっています。例えば、2023年10月、ハウテン州固形臓器移植部門とウィットウォーターズランド大学シャーロット・マクセキ学術病院の後援のもと、胆道閉鎖症啓発委員会が胆道閉鎖症啓発キャンペーンを開始しました。このキャンペーンは、胆管の閉塞や消失によって乳幼児が罹患する、まれで生命を脅かす肝臓病である胆道閉鎖症に罹患した子どもたちへの意識向上と支援を目的としたものです。このイニシアチブは、胆道閉鎖症について多様な層を啓蒙し、罹患家族に調査と支援を提供し、診断ツールや治療法の研究を促進し、世界の医療機関との協力を促進することに重点を置いていました。

高齢化は内視鏡的逆行性胆管膵管造影市場の成長を促す重要な要因です。世界人口の高齢化が進むにつれ、輸血を必要とする手術など、これらの処置に対する需要が高まっています。胆管症、貧血、外科的求血などの慢性疾患は、成人人口の増加とともに増加し続けています。現在、米国だけでも65歳以上の人口は4,000万人を超えており、その数は2050年までに倍増すると予想されています。日本は世界で最も高齢者が多いため、この市場に潜在的な成長機会を提供しています。WHOによると、高齢者の割合は2050年までに22.0%に達すると予想されています。

さらに、いくつかの医療機関は、革新的な製品の研究開発のためにパートナーシップを含むイニシアチブを採用しており、それによって市場の成長に拍車をかけています。例えば、2022年7月にOptica Publishing Group誌に掲載された調査研究によると、School of Biomedical Engineering &Imaging Sciencesの研究者は、内径0.6ミリの医療用針に挿入可能な光音響イメージング内視鏡プローブを開発しました。また、人工知能（AI）を活用することで、画像診断を迅速化できる可能性も示唆しました。

さらに、M&Aや製品発表など、市場参入企業が採用する戦略的イニシアチブは、予測期間にわたって市場を牽引すると予測されています。例えば、2022年4月、Olympusは止血領域の技術開発に注力するEndoClot Plusと提携しました。EndoClot Plusの主要製品の1つはEndoClot PHSで、消化管出血を非熱的、非外傷的に止血する方法です。今回の合意は、EndoClot PHSを消化器内科医がより利用しやすくし、医療処置中の出血を迅速かつ確実に止血できるようにすることを目的としています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 内視鏡的逆行性胆道膵管造影市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/付随市場の展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 内視鏡的逆行性胆道膵管造影市場分析ツール
  • 産業分析-ポーターのファイブフォース分析
  • PESTEL分析

第4章 内視鏡的逆行性胆道膵管造影市場：製品別、推定・動向分析

• セグメントダッシュボード
• 内視鏡的逆行性胆道膵管造影検査市場：製品変動分析
• 内視鏡的逆行性胆道膵管造影市場の製品別展望
• 2018～2030年の市場規模と予測と動向分析
• 内視鏡
• 内視鏡治療装置
  • 括約筋切開術
  • 砕石器
  • ステント
  • カニューレ
  • 鉗子
  • スネア
  • カテーテル
  • ガイドワイヤ
  • 風船
  • バスケット
• 可視化システム
• エネルギーデバイス
• その他

第5章 内視鏡的逆行性胆道膵管造影市場：手技タイプ別、推定・動向分析

• セグメントダッシュボード
• 内視鏡的逆行性胆道膵管造影検査市場：手技タイプ変動分析
• 内視鏡的逆行性胆道膵管造影市場の手技タイプ別展望
• 2018～2030年の市場規模と予測と動向分析
• 胆道括約筋切開術
• 胆管ステント
• 胆管拡大症
• 膵括約筋切開術
• 膵管ステント留置術
• 膵管拡大

第6章 内視鏡的逆行性胆道膵管造影市場：最終用途別、推定・動向分析

• セグメントダッシュボード
• 内視鏡的逆行性胆道膵管造影検査市場：最終用途変動分析
• 内視鏡的逆行性胆道膵管造影市場の最終用途別展望
• 2018～2030年の市場規模と予測と動向分析
• 病院
• 外来施設

第7章 内視鏡的逆行性胆道膵管造影市場：地域別、推定・動向分析

• 地域ダッシュボード
• 内視鏡的逆行性胆道膵管造影の市場変動分析
• 内視鏡的逆行性胆道膵管造影市場：技術と最終用途による地域推定・動向分析
• 2018～2030年の市場規模と予測と動向分析
• 北米
  • 米国
  • カナダ
  • メキシコ
  • 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 市場参入企業の分類
• 主要企業プロファイル
  • Olympus Corporation
  • CONMED Corporation
  • Boston Scientific Corporation
  • Medtronic PLC
  • Telemed System, Inc.
  • AMBU, Inc.
  • FUJIFILM Holdings Corporation
  • Hobbs Medical, Inc.
  • Cook Group
  • Streis PLC
  • HOYA Group
  • Karl Storz SE &Co. KG

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
• Table 4 Global Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
• Table 5 Global Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
• Table 6 North America Endoscopic Retrograde Cholangiopancreatography market, by region, 2018 - 2030 (USD Million)
• Table 7 North America Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
• Table 8 North America Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
• Table 9 North America Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
• Table 10 U.S. Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
• Table 11 U.S. Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
• Table 12 U.S. Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
• Table 13 Mexico Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
• Table 14 Mexico Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
• Table 15 Mexico Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million
• Table 16 Canada Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
• Table 17 Canada Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
• Table 18 Canada Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
• Table 19 Europe Endoscopic Retrograde Cholangiopancreatography market, by country, 2018 - 2030 (USD Million)
• Table 20 Europe Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
• Table 21 Europe Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
• Table 22 Europe Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
• Table 23 UK Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
• Table 24 UK Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
• Table 25 UK Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
• Table 26 Germany Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
• Table 27 Germany Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
• Table 28 Germany Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
• Table 29 France Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
• Table 30 France Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
• Table 31 France Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
• Table 32 Italy Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
• Table 33 Italy Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
• Table 34 Italy Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
• Table 35 Spain Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
• Table 36 Spain Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
• Table 37 Spain Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
• Table 38 Norway Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
• Table 39 Norway Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
• Table 40 Norway Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
• Table 41 Sweden Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
• Table 42 Sweden Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
• Table 43 Sweden Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
• Table 44 Denmark Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
• Table 45 Denmark Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
• Table 46 Denmark Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
• Table 47 Asia Pacific Endoscopic Retrograde Cholangiopancreatography market, by country, 2018 - 2030 (USD Million)
• Table 48 Asia Pacific Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
• Table 50 Asia Pacific Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
• Table 51 Japan Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
• Table 52 Japan Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
• Table 53 Japan Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
• Table 54 China Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
• Table 55 China Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
• Table 56 China Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
• Table 57 India Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
• Table 58 India Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
• Table 59 India Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
• Table 60 Australia Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
• Table 61 Australia Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
• Table 62 Australia Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
• Table 63 South Korea Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
• Table 64 South Korea Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
• Table 65 South Korea Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
• Table 66 Thailand Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
• Table 67 Thailand Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
• Table 68 Thailand Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
• Table 69 Latin America Endoscopic Retrograde Cholangiopancreatography market, by country, 2018 - 2030 (USD Million)
• Table 70 Latin America Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
• Table 71 Latin America Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
• Table 72 Latin America Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
• Table 73 Brazil Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
• Table 74 Brazil Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
• Table 75 Brazil Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
• Table 76 Argentina Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
• Table 77 Argentina Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
• Table 78 Argentina Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
• Table 79 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography market, by country, 2018 - 2030 (USD Million)
• Table 80 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
• Table 81 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
• Table 82 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
• Table 83 South Africa Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
• Table 84 South Africa Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
• Table 85 South Africa Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
• Table 86 Saudi Arabia Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
• Table 88 Saudi Arabia Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
• Table 89 UAE Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
• Table 90 UAE Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
• Table 91 UAE Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
• Table 92 Kuwait Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
• Table 93 Kuwait Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
• Table 94 Kuwait Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 Endoscopic Retrograde Cholangiopancreatography market segmentation
• Fig. 7 Market driver analysis (Current & future impact)
• Fig. 8 Market restraint analysis (Current & future impact)
• Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 10 Porter's Five Forces Analysis
• Fig. 11 Endoscopic Retrograde Cholangiopancreatography market, product outlook key takeaways (USD Million)
• Fig. 12 Endoscopes market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 13 Endotherapy devices market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 14 Sphincterotomes market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 15 Lithotripter market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 16 Stents market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 17 Cannulas market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 18 Forceps market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 19 Snares market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 20 Catheters market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 21 Guiding wires market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 22 Balloons market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 23 Baskets market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 24 Visualization systems market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 25 Energy devices market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 26 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 27 Endoscopic Retrograde Cholangiopancreatography market, Procedure outlook key takeaways (USD Million)
• Fig. 28 Endoscopic Retrograde Cholangiopancreatography market: Procedure movement analysis 2023 & 2030 (USD Million)
• Fig. 29 Biliary sphincterotomy market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 30 Biliary stenting market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 31 Biliary dilatation market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 32 Pancreatic sphincterotomy market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Pancreatic duct stenting market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Pancreatic duct dilation market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 35 Endoscopic Retrograde Cholangiopancreatography market, end use outlook key takeaways (USD Million)
• Fig. 36 Endoscopic Retrograde Cholangiopancreatography market: end use movement analysis 2023 & 2030 (USD Million)
• Fig. 37 Hospitals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 Outpatient facilities market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Endoscopic Retrograde Cholangiopancreatography market: Regional key takeaways (USD Million)
• Fig. 40 Endoscopic Retrograde Cholangiopancreatography market: regional outlook, 2023 & 2030, USD Million
• Fig. 41 North America Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 U.S. Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Canada Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Mexico Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45 Europe Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 UK Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Germany Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 France Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Spain Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Italy Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Sweden Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Norway Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Denmark Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Asia Pacific Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 China Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Japan Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 India Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 South Korea Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Australia Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 60 Thailand Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 61 Latin America Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 62 Brazil Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 63 Argentina Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 64 Middle East and Africa Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 65 South Africa Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 66 Saudi Arabia Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 67 UAE Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 68 Kuwait Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 69 List of key emerging company's/technology disruptors/innovators

Market Size & Trends:

The global endoscopic retrograde cholangiopancreatography market size was estimated at USD 2.17 billion in 2024 and is anticipated to grow at a CAGR of 8.26% from 2025 to 2030. This growth is majorly driven by the rising incidence of pancreatic and biliary diseases such as gallstones, pancreatitis, and bile duct obstructions are fueling the demand for ERCP procedures. As the population ages and lifestyles change, the prevalence of these conditions is expected to increase, driving market growth. According to Clinical Gastroenterology and Hepatology study published in February 2024, there is an estimated 6% prevalence of gallstones globally, with higher rates observed in females and in South America. According to studies, the incidence rate of gallstones is anticipated to rise sharply over the forecast period, thereby driving the demand for endoscopic retrograde cholangiopancreatography (ERCP) procedures.

Furthermore, advances in endoscopic technology have improved the safety and efficacy of ERCP procedures. For instance, in January 2023, Advantech introduced the MIO-5377R single board computer as a groundbreaking innovation in the field of endoscope technology. This compact and powerful device is designed to address the traditional challenges faced by endoscopes, offering enhanced performance, reliability, and functionality. Moreover, innovations such as high-definition imaging, better maneuverability of endoscopes, and the development of therapeutic accessories have made ERCP a more precise and effective diagnostic and treatment tool. These technological advancements are attracting both healthcare providers and patients to opt for ERCP procedures.

The rise in the adoption of minimally invasive surgical techniques has led to an increased demand for ERCP procedures, which is expected to drive growth in the industry in the upcoming years. For instance, according to the American Cancer Society's annual report published in January 2024, an estimated 41,630 new cases of liver cancer are expected to be diagnosed in the U.S. Additionally, as per the same source, liver cancer is more prevalent in countries in sub- Southeast Asia and Saharan Africa compared to the U.S. It is the most common type of cancer in many of these nations, with over 800,000 new cases diagnosed globally each year. Additionally, liver cancer ranks as a leading cause of cancer-related deaths worldwide, claiming more than 700,000 lives annually.

The high burden of cholangiocarcinoma and hepatocellular carcinoma is expected to boost the demand for endoscopic retrograde cholangiopancreatography for the early detection of such malignancies.

Moreover, the increased awareness about the benefits of early diagnosis and treatment of pancreatic and biliary diseases has led to a higher demand for minimally invasive procedures such as ERCP. For instance, in October 2023. the Biliary Atresia Awareness Committee launched Biliary Atresia Awareness Campaign under the auspices of Gauteng Provincial Solid Organ Transplant Division and the University of the Witwatersrand at Charlotte Maxeke Academic Hospital. The campaign was aimed to raise awareness and support for children affected by biliary atresia, a rare and life-threatening liver disease that affects infants by obstructing or obliterating bile ducts. The initiative was focused on educating diverse demographics about biliary atresia, offering resources and support to affected families, advancing research for diagnostic tools and treatments, and fostering collaboration with medical entities globally.

The aging population is a significant factor driving the growth of the endoscopic retrograde cholangiopancreatography market. As the global population continues to age, there is a growing demand for these procedures, including surgeries that require blood transfusions. Chronic diseases such as caugulopathy, anemia, and surgical blood seeking continue to increase along with the increase in adult population. Currently , there are over 40 million people in the U.S. alone above 65 years and the number are expected to double by 2050. Japan provides potential growth opportunities to this market due to the presence of the highest geriatric population in the globe. According to WHO, the percentage of the geriatric population is expected to reach 22.0% by 2050.

Additionally, several healthcare organizations are adopting initiatives including partnerships for the R&D of innovative products, thereby fueling the market growth. For instance , according to research study published in Optica Publishing Group journal in July 2022, researchers at the School of Biomedical Engineering & Imaging Sciences developed a photoacoustic imaging endoscope probe which can be inserted into a medical needle with an inner diameter as small as 0.6 millimeters. They also suggested that artificial intelligence (AI) could be utilized to accelerate imaging procedures.

Furthermore, the strategic initiatives adopted by the market players, such as mergers, and acquisitions, and product launches are projected to drive the market over the forecast period. For instance, in April 2022, Olympus partnered with EndoClot Plus, a company that focuses on developing technologies in the hemostasis space. One of the key products in EndoClot Plus' portfolio is the EndoClot PHS, a nonthermal, nontraumatic method for achieving hemostasis with gastrointestinal (GI) bleeds. This agreement aims to make the EndoClot PHS more accessible to gastroenterologists, enabling them to stop bleeding rapidly and reliably during medical procedures.

Global Endoscopic Retrograde Cholangiopancreatography Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global endoscopic retrograde cholangiopancreatography market report based on product, procedure, end use and region:

• Product Outlook (Revenue, USD Million, 2018 - 2030)
• Endoscopes
• Endotherapy Devices
  • Sphincterotomes
  • Lithotripter
  • Stents
  • Cannulas
  • Forceps
  • Snares
  • Catheters
  • Guiding Wires
  • Balloons
  • Baskets
• Visualization Systems
• Energy Devices
• Others
• Procedure Outlook (Revenue, USD Million, 2018 - 2030)
• Biliary Sphincterotomy
• Biliary Stenting
• Biliary Dilatation
• Pancreatic Sphincterotomy
• Pancreatic Duct Stenting
• Pancreatic Duct Dilation
• End use Outlook (Revenue, USD Million, 2018 - 2030)
• Hospitals
• Outpatient Facilities
• Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Norway
  • Sweden
  • Denmark
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Procedure
  • 1.2.3. End use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Procedure outlook
  • 2.2.3. End use outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Endoscopic Retrograde Cholangiopancreatography Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Endoscopic Retrograde Cholangiopancreatography Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Endoscopic Retrograde Cholangiopancreatography Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Endoscopic Retrograde Cholangiopancreatography Market: Product Movement Analysis
• 4.3. Endoscopic Retrograde Cholangiopancreatography Market by Product Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Endoscopes
  • 4.5.1. Endoscopes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Endotherapy Devices
  • 4.6.1. Endotherapy Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.2. Sphincterotomes
    • 4.6.2.1. Sphincterotomes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.3. Lithotripter
    • 4.6.3.1. Lithotripter Market Revenue Estimates and Fo recasts, 2018 - 2030 (USD Million)
  • 4.6.4. Stents
    • 4.6.4.1. Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.5. Cannulas
    • 4.6.5.1. Cannulas Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.6. Forceps
    • 4.6.6.1. Forceps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.7. Snares
    • 4.6.7.1. Snares Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.8. Catheters
    • 4.6.8.1. Catheters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.9. Guiding Wires
    • 4.6.9.1. Guiding Wires Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.10. Balloons
    • 4.6.10.1. Balloons Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.11. Baskets
    • 4.6.11.1. Baskets Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Visualization Systems
  • 4.7.1. Visualization Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.8. Energy Devices
  • 4.8.1. Energy Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.9. Others
  • 4.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Endoscopic Retrograde Cholangiopancreatography Market: Procedure Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Endoscopic Retrograde Cholangiopancreatography Market: Procedure Movement Analysis
• 5.3. Endoscopic Retrograde Cholangiopancreatography Market by Procedure Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Biliary Sphincterotomy
  • 5.5.1. Biliary Sphincterotomy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Biliary Stenting
  • 5.6.1. Biliary Stenting Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Biliary Dilatation
  • 5.7.1. Biliary Dilatation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. Pancreatic Sphincterotomy
  • 5.8.1. Pancreatic Sphincterotomy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.9. Pancreatic Duct Stenting
  • 5.9.1. Pancreatic Duct Stenting Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.10. Pancreatic Duct Dilation
  • 5.10.1. Pancreatic Duct Dilation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Endoscopic Retrograde Cholangiopancreatography Market: End use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Endoscopic Retrograde Cholangiopancreatography Market: End use Movement Analysis
• 6.3. Endoscopic Retrograde Cholangiopancreatography Market by End use Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Hospitals
  • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Outpatient Facilities
  • 6.6.1. Outpatient Facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Endoscopic Retrograde Cholangiopancreatography Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Regional Endoscopic Retrograde Cholangiopancreatography Market movement analysis
• 7.3. Endoscopic Retrograde Cholangiopancreatography Market: Regional Estimates & Trend Analysis by Technology & End use
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 7.5. North America
  • 7.5.1. North America Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. U.S. Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. Canada Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. Reimbursement scenario
    • 7.5.4.5. Mexico Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Europe
  • 7.5.6. Europe Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. UK
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Framework
    • 7.5.7.4. Reimbursement scenario
    • 7.5.7.5. UK Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.8. Germany
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Competitive Scenario
    • 7.5.8.3. Regulatory Framework
    • 7.5.8.4. Reimbursement scenario
    • 7.5.8.5. Germany Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.9. France
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Competitive Scenario
    • 7.5.9.3. Regulatory Framework
    • 7.5.9.4. Reimbursement scenario
    • 7.5.9.5. France Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.10. Italy
    • 7.5.10.1. Key Country Dynamics
    • 7.5.10.2. Competitive Scenario
    • 7.5.10.3. Regulatory Framework
    • 7.5.10.4. Reimbursement scenario
    • 7.5.10.5. Italy Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.11. Spain
    • 7.5.11.1. Key Country Dynamics
    • 7.5.11.2. Competitive Scenario
    • 7.5.11.3. Regulatory Framework
    • 7.5.11.4. Reimbursement scenario
    • 7.5.11.5. Spain Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.12. Denmark
    • 7.5.12.1. Key Country Dynamics
    • 7.5.12.2. Competitive Scenario
    • 7.5.12.3. Regulatory Framework
    • 7.5.12.4. Reimbursement scenario
    • 7.5.12.5. Denmark Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.13. Sweden
    • 7.5.13.1. Key Country Dynamics
    • 7.5.13.2. Competitive Scenario
    • 7.5.13.3. Regulatory Framework
    • 7.5.13.4. Reimbursement scenario
    • 7.5.13.5. Sweden Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.14. Norway
    • 7.5.14.1. Key Country Dynamics
    • 7.5.14.2. Competitive Scenario
    • 7.5.14.3. Regulatory Framework
    • 7.5.14.4. Reimbursement scenario
    • 7.5.14.5. Norway Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. Japan Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. China Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. Reimbursement scenario
    • 7.6.4.5. India Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Reimbursement scenario
    • 7.6.5.5. South Korea Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. Australia
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Competitive Scenario
    • 7.6.6.3. Regulatory Framework
    • 7.6.6.4. Reimbursement scenario
    • 7.6.6.5. Australia Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Competitive Scenario
    • 7.6.7.3. Regulatory Framework
    • 7.6.7.4. Reimbursement scenario
    • 7.6.7.5. Thailand Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. Brazil Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. Argentina Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.8. Middle East & Africa
  • 7.8.1. Middle East & Africa Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory Framework
    • 7.8.2.4. Reimbursement scenario
    • 7.8.2.5. South Africa Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory Framework
    • 7.8.3.4. Reimbursement scenario
    • 7.8.3.5. Saudi Arabia Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Competitive Scenario
    • 7.8.4.3. Regulatory Framework
    • 7.8.4.4. Reimbursement scenario
    • 7.8.4.5. UAE Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Competitive Scenario
    • 7.8.5.3. Regulatory Framework
    • 7.8.5.4. Reimbursement scenario
    • 7.8.5.5. Kuwait Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. Olympus Corporation
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Product benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. CONMED Corporation
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. Boston Scientific Corporation
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. Medtronic PLC
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. Telemed System, Inc.
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. AMBU, Inc.
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. FUJIFILM Holdings Corporation
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. Hobbs Medical, Inc.
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. Cook Group
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. Streis PLC
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives
  • 8.2.11. HOYA Group
    • 8.2.11.1. Company overview
    • 8.2.11.2. Financial performance
    • 8.2.11.3. Product benchmarking
    • 8.2.11.4. Strategic initiatives
  • 8.2.12. Karl Storz SE & Co. KG
    • 8.2.12.1. Company overview
    • 8.2.12.2. Financial performance
    • 8.2.12.3. Product benchmarking
    • 8.2.12.4. Strategic initiatives